Advanced Filters
noise
Found 919 clinical trials
A Antonia Seligowski, PhD

Determining the Benefits of Exercise on Cardiovascular Risk in PTSD

The purpose of this study is to use a non-invasive imaging technique called positron emission tomography/magnetic resonance imaging (PET/MRI) to investigate the effects of exercise on brain activity and arterial (blood vessel) inflammation in people with PTSD symptoms and evidence of or elevated risk for artery disease.

18 - 65 years of age All Phase N/A
J Jenni Wise, PhD, MSN

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

Women living with HIV have 2-4x higher risk for cardiovascular disease compared to women without HIV, with women living with HIV in the Southern US being particularly at risk. While an increased prevalence of traditional risk factors (e.g., hypertension, diabetes, and obesity) partially explain this risk, evidence suggests that increased …

18 years of age Female Phase N/A

Post-Operative Biomarker-Guided Precision Medicine For Cardiovascular Risk Reduction

The goal of this pilot study is to assess enrollment feasibility of a randomized trial of direct oral anticoagulant and high-intensity statin therapy versus usual care in patients with Myocardial Injury after Noncardiac Surgery (MINS). The primary aims of this study are to assess feasibility, study drug adherence, and optimize …

45 years of age All Phase N/A
J Jeremy A Bigalke, PhD

Influence of Melatonin on Cardiovascular and Thermoregulatory Responses to Stress

This study aims to evaluate the influence of acute oral melatonin supplementation on cardiovascular and skin temperature responses to mental stress. The hypothesis is that acute melatonin will lead to reduced cardiovascular and skin temperature responsiveness to acute mental stress.

18 - 70 years of age All Phase N/A
O Ophir Freund, MD

Cardiovascular Assessment During COPD Exacerbation to Improve Diagnosis and Treatment

This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out …

18 - 75 years of age All Phase N/A
C Cyndya Shibao, MD, MSCI

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

The term post-acute COVID-19 syndrome or Long COVID is a disabling syndrome that persists beyond the 3-month convalescence period after COVID-19 infections. This syndrome affects mostly women (~80%), present with chronic tachycardia and Orthostatic intolerance symptoms without any identifiable cause. In addition, non-specific symptoms such as fatigue, headache, and "brain …

18 years of age All Phase N/A
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Dietary Behavior Intervention in African Americans at Risk for Cardiovascular Disease

Background The risk of heart disease among African Americans is still common despite a greater understanding of the disease and better approaches to managing it. Healthy cooking and eating patterns can help reduce the risk of heart disease. But things like access to grocery stores and knowledge of good nutrition …

18 - 99 years of age All Phase N/A
C Clinical Research Office

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

This study aims to determine whether changes in retinal vasculature seen on SS-OCTA can be correlated to degree of cardiovascular disease as measured by carotid duplex ultrasonography.

18 - 80 years of age All Phase N/A

Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study

This research study aims to learn more about the impact the hormone aldosterone on the heart. Primary aldosteronism is a condition where the body's adrenal glands make too much of the hormone aldosterone, which can cause high blood pressure and increase the risk of heart and kidney disease. Treatment with …

18 - 85 years of age All Phase 4
J Jorge Wong, MD

Bariatric Surgery for the Reduction of CArdioVascular Events Randomized Controlled Trial

The primary objective of this study is to evaluate if, in patients with severe obesity (body mass index (BMI) ≥30 kg/m2) and high-risk cardiovascular disease (CVD), bariatric surgery compared to medical weight management (MWM) safely reduces the risk of major cardiovascular events. The cost-effectiveness of bariatric surgery will also be …

18 years of age All Phase N/A

Simplify language using AI